Rekvina Labs

33
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE092O01028
  • NSEID:
  • BSEID: 526075
INR
25.25
0.25 (1.0%)
BSENSE

Aug 04, 03:30 PM

BSE+NSE Vol: 1.42 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'18
Mar'17
Mar'16
Mar'15
Mar'14
Mar'13
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2018 is 0.00% vs -100.00% in Mar 2017

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2018 is -108.17% vs 15.75% in Mar 2017

stock-summary

Interest

YoY Growth in year ended Mar 2018 is -6.26% vs -35.72% in Mar 2017

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2018 is -314.17% vs 65.91% in Mar 2017

Compare Profit and Loss Results of Rekvina Labs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
0.00
20,754.00
-20,754.00
-100.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
0.00
20,754.00
-20,754.00
-100.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-305.00
305.00
100.00%
Raw Materials Consumed
0.00
5,774.00
-5,774.00
-100.00%
Power & Fuel Cost
0.00
488.00
-488.00
-100.00%
Employee Cost
0.00
2,911.00
-2,911.00
-100.00%
Operating Expenses
0.00
1,434.00
-1,434.00
-100.00%
General and Administration Expenses
0.00
-1.00
1.00
100.00%
Selling and Distribution Expenses
0.00
2,471.00
-2,471.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
490.00
-490.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
0.00
15,931.00
-15,931.00
-100.00%
Operating Profit (PBDIT) excl Other Income
0.00
4,823.00
-4,823.00
-100.00%
Other Income
0.00
1,776.00
-1,776.00
-100.00%
Operating Profit (PBDIT)
0.00
6,600.00
-6,600.00
-100.00%
Interest
0.00
947.00
-947.00
-100.00%
Profit before Depriciation and Tax
0.00
5,652.00
-5,652.00
-100.00%
Depreciation
0.00
1,311.00
-1,311.00
-100.00%
Profit Before Taxation & Exceptional Items
0.00
4,340.00
-4,340.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
3,794.00
-3,794.00
-100.00%
Provision for Tax
0.00
1,170.00
-1,170.00
-100.00%
Profit After Tax
0.00
2,623.00
-2,623.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-2.00
12,948.00
-12,950.00
-100.02%
Profit Available for appropriations
-2.00
15,571.00
-15,573.00
-100.01%
Appropriations
-2.00
15,571.00
-15,573.00
-100.01%
Equity Dividend (%)
0%
1600%
-1,600.00
Earnings Per Share
-0.13
10.9
-11.03
-101.19%
Profit And Loss - Net Sales
Net Sales 0.00 Cr
in Mar 2018

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2018 is 0.00% vs -100.00% in Mar 2017

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.10 Cr
in Mar 2018

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2018 is -108.17% vs 15.75% in Mar 2017

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2018

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2018 is -6.26% vs -35.72% in Mar 2017

Profit And Loss - Profit After Tax
Profit After Tax -0.08 Cr
in Mar 2018

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2018 is -314.17% vs 65.91% in Mar 2017